Cargando…
GPR160 is a potential biomarker associated with prostate cancer
Autores principales: | Guo, Wanjing, Zhang, Junyu, Zhou, Yan, Zhou, Caihong, Yang, Yunjie, Cong, Zhaotong, Dong, Jibin, Yang, Dehua, Dai, Bo, Wang, Ming-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225807/ https://www.ncbi.nlm.nih.gov/pubmed/34168114 http://dx.doi.org/10.1038/s41392-021-00583-7 |
Ejemplares similares
-
G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells
por: Zhou, Caihong, et al.
Publicado: (2016) -
Structural analysis of the dual agonism at GLP-1R and GCGR
por: Li, Yang, et al.
Publicado: (2023) -
Plasmakinetic enucleation of prostate versus 160-W laser photoselective vaporization for the treatment of benign prostatic hyperplasia
por: Wang, Si-Jun, et al.
Publicado: (2017) -
Potential Epigenetic Biomarkers for Prostate Cancer Screening
por: Bae, Jong-Myon
Publicado: (2018) -
GPR-160 Receptor Signaling in the Dorsal Vagal Complex of Male Rats Modulates Meal Microstructure and CART-Mediated Hypophagia
por: Sanchez-Navarro, Marcos J., et al.
Publicado: (2023)